US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 21, 2016 (10 years ago)

Mitomycin Solution Injectable

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Mitomycin Solution Injectable, Sterile 0.04%, 400 mcg/mL, 1 mL syringe, Compounded by Wells Pharmacy, Ocala, FL

Recalling firm
Wells Pharmacy Network LLC
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0378-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Mitomycin recalls

See all
Class II · Moderate risk Terminated

Mitomycin Injection Solution

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0102-2023
Class II · Moderate risk Terminated

Mitomycin 0.4mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0224-2023
Class II · Moderate risk Terminated

Mitomycin 0.2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0223-2023
Class II · Moderate risk Ongoing

MITOMYCIN INJECTION 0.375 mg/mL SYR

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0039-2023
Class II · Moderate risk Terminated

Mitomycin-C

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1011-01 D-0409-2022